对心脏中的β-上腺素受体信号的差异性下调
Bing Xu1,2, Sherif Bahriz2,3, Victoria R Salemme2
1VA Northern California Health Care System Mather CA USA.
Journal of the American Heart Association
|June 11, 2024
概括
慢性同情性刺激使心脏β1上腺素受体 (β1AR) 变得不敏感. 这项研究揭示了不同的细胞下信号下调机制,影响心力衰竭的进展.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性同情性刺激导致β1上腺素受体 (β1AR) 脱敏和降低心力衰竭的调节.
- 了解差异性亚细胞β1AR信号池对于心力衰竭研究至关重要.
研究的目的:
- 研究慢性上腺刺激下心脏中亚细胞β1AR信号池的明显下调机制.
- 探索慢性异二醇输注对小鼠心室肌细胞中β1AR局部化和信号传递的影响.
主要方法:
- 慢性异二醇输液在小鼠中诱导心肌病.
- 聚焦显微镜,近距离结合测试和福斯特共振能量转移 (FRET) 生物传感器来分析β1AR相互作用和信号.
- 评估固酶 (PDE) 蛋白水平及其在β1AR-PKA信号传递中的作用.
主要成果:
- 慢性异二醇降低了β1AR水平及其与L型通道和氨酸受体的关联,损害了血膜和氨酸受体相关的PKA信号传递.
- 与SERCA2a的β1AR相关性得到增强,但内源性北上腺素诱导的SERCA2a信号传递仍然减少.
- 改变PDE表达 (减少PDE4D/PDE3A,增加PDE2A/PDE4A/PDE4B) 调节了β1AR-PKA活性和肌细胞缩短.
结论:
- 慢性上腺刺激会诱导亚细胞β1AR信号池的差异性下调.
- 特定的PDE异型在调节β1AR-PKA信号局部化和功能方面发挥着关键作用.
- 针对特定的途径,如MAO-A抑制,可以恢复上腺体信号传递和心脏功能.
相关概念视频
Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
Antihypertensive Drugs: Action of β1 Blockers
427
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
427
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
709
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
709
Adrenergic Receptors (Adrenoceptors): Classification
2.5K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.5K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
432
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
432
Antihypertensive Drugs: Types of β-Blockers
642
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
642


